Vaccine Impact on Dementia and Shingles

This chapter explores the influence of the Zostavax vaccine on shingles incidence and its potential protective effects against dementia. It presents statistical analyses revealing a reduction in dementia diagnoses associated with vaccination and discusses the complexities of observational studies in this context. Additionally, the chapter highlights the nuances of health care interactions and the implications of transitioning to the Shingrix vaccine.